You are here: 

Carcinoembryonic antigen (CEA)

Carcinoembryonic antigen (CEA) is a protein normally found in very low levels in the blood of adults. The CEA blood level may be increased in certain types of cancer and non-cancerous (benign) conditions. A CEA test is most commonly used for colorectal cancer.

Why a CEA test is done

A CEA test may be done:

  • if the doctor suspects there may be cancer
  • to find out if cancer treatment is working
  • to find out if cancer has come back (recurred) after treatment

How a CEA test is done

A CEA test is usually a blood test that measures the amount of CEA protein in the blood. A sample of blood is taken by inserting a needle into the vein in your arm. No special preparation is needed.

What the results mean

An increased CEA value can occur in both cancers and non-cancerous conditions.


The CEA blood levels are often increased in colorectal cancer and may be increased in other cancers including:

  • breast
  • lung
  • pancreatic
  • stomach
  • liver
  • ovarian

After treatment, a return to a normal CEA level that had been elevated usually means that the cancer has responded to treatment.

A CEA level that rises steadily after treatment is complete often means that the cancer has come back (recurred).

Non-cancerous conditions

The CEA blood level may be increased in non-cancerous conditions including:

  • a peptic ulcer
  • ulcerative colitis
  • rectal polyps
  • emphysema
  • benign breast disease
  • an inflammation such as pancreatitis (inflammation of the pancreas) or cholecystitis (inflammation of the gallbladder)

Smokers who do not have cancer can also have an increased CEA value.

What happens if the result is abnormal

The doctor will decide whether further tests, procedures, follow-up care or additional treatment are needed.


A teenaged girl sitting on her bed I was in total shock when I heard the diagnosis of cancer. Cancer to me was an adult’s disease. Being a 13-year-old teenager, it certainly wasn’t even on my radar.

Read Sabrina's story

Together we can reduce the burden of cancer

Icon - beaker

Last year, we only had the resources available to fund 40% of high-priority research projects. Imagine the impact we could have if we were able to fund 100%.

Learn more